Cancer Biotherapy and Radiopharmaceuticals Cancer Biotherapy and Radiopharmaceuticals RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Serum-Derived Exosomes-Mediated Circular RNA ARHGAP10 Modulates the Progression of Non-Small Cell Lung Cancer Through the miR-638/FAM83F Axis
Cancer Biotherapy and Radiopharmaceuticals,Volume 37, Issue 2, Page 96-110, March 2022. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - March 15, 2022 Category: Cancer & Oncology Authors: Ke Fang Xuan Chen Feng Qiu Jinbiao Xu Huanwen Xiong Zhanmin Zhang Source Type: research

Circ_0074027 Contributes to Non-Small Cell Lung Cancer Progression by Upregulating CUL4B Expression Through miR-335-5p
Cancer Biotherapy and Radiopharmaceuticals,Volume 37, Issue 2, Page 73-83, March 2022. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - March 15, 2022 Category: Cancer & Oncology Authors: Chaoqun Yu Jianjian Ying Kaizhong Yu Weiyu Shen Maofen Jiang Source Type: research

SND1 Promotes Radioresistance in Cervical Cancer Cells by Targeting the DNA Damage Response
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - March 10, 2022 Category: Cancer & Oncology Authors: Xiao Fu Zhongchao Duan Xin Lu Yingyu Zhu Yuanyuan Ren Wei Zhang Xiaoming Sun Lin Ge Jie Yang Source Type: research

RNA Interference Induces BRCA1 Gene Methylation and Increases the Radiosensitivity of Breast Cancer Cells
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - February 18, 2022 Category: Cancer & Oncology Authors: Yuebin Shi Rui Huang Yong Zhang Qiang Feng Xinyan Pan Li Wang Source Type: research

Hematological Markers as Predictors of Treatment Outcomes with Lutetium 177 (177Lu)-DOTATATE in Patients with Advanced Neuroendocrine Tumors
Cancer Biotherapy and Radiopharmaceuticals,Volume 37, Issue 1, Page 23-29, February 2022. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - February 8, 2022 Category: Cancer & Oncology Authors: Swayamjeet Satapathy Anish Bhattacharya Ashwani Sood Rakesh Kapoor Rajesh Gupta Apurva Sood Prashant Sharma Divya Khosla Bhagwant Rai Mittal Source Type: research

An Analysis for Therapeutic Doses of Patients with Neuroendocrine Tumor Treated with Lutetium 177 (177Lu)-DOTATATE
Cancer Biotherapy and Radiopharmaceuticals,Volume 37, Issue 1, Page 17-22, February 2022. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - February 8, 2022 Category: Cancer & Oncology Authors: Bilal Kovan Zeynep G özde Özkan Bayram Demir Duygu Tun çman Emine G öknur Işik Duygu Has Şimşek Fikret B üyükkaya C üneyt Türkmen Yasemin Şanli Source Type: research

A Pilot Study of Hepatic Irradiation with Yttrium-90 Microspheres Followed by Immunotherapy with Ipilimumab and Nivolumab for Metastatic Uveal Melanoma
Cancer Biotherapy and Radiopharmaceuticals,Volume 37, Issue 1, Page 11-16, February 2022. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - February 8, 2022 Category: Cancer & Oncology Authors: David R. Minor Kevin B. Kim Ricky T. Tong Max C. Wu Mohammed Kashani-Sabet Marlana Orloff David J. Eschelman Carlin F. Gonsalves Robert D. Adamo Pramila R. Anne Jason J. Luke Devron Char Takami Sato Source Type: research

Cutaneous Squamous Cell Carcinoma Subjected to Anti PD-1 Immunotherapy: Monitoring Response Through Serial PET/CT Scans with 18F-FDG
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - February 4, 2022 Category: Cancer & Oncology Authors: Luca Filippi Ilaria Proietti Vincenzo Petrozza Oreste Bagni Orazio Schillaci Source Type: research

Downregulated Wnt2B Expression Suppresses Proliferation, Invasion, and Angiogenesis of Ovarian Cancer Cells Through Inhibiting the Wnt/ β-Catenin Signaling Pathway
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - February 4, 2022 Category: Cancer & Oncology Authors: Shengsheng Yu Xing Pen Haoyu Zheng Qiong Gao Haidong Wang Source Type: research

A Facile Strategy for Preparation of Yttrium-90 Therapeutic Sources for Radionuclide Therapy
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - January 25, 2022 Category: Cancer & Oncology Authors: Archana Mukherjee Usha Pandey Samina H. Shaikh Manoj Kumar Vivek Kaushik Poonam Jagasia Sanjukta A. Kumar Prem Singh Dhami Source Type: research

A Novel Scoring System in Predicting Prognosis After Adjuvant FOLFOX Chemotherapy in Gastric Cancer
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - January 25, 2022 Category: Cancer & Oncology Authors: Guochao Ge Guangyao Li Zhengjun Zhang Yong Zhu Wentao Wang Lei Ren Ziqiang Li Mujian Teng Source Type: research

miR-584-5p Inhibits Osteosarcoma Progression by Targeting Connective Tissue Growth Factor
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - January 17, 2022 Category: Cancer & Oncology Authors: Qian Lu Yongli Wang Xuesheng Jiang Sheng Huang Source Type: research

miRNA-381-3p Functions as a Tumor Suppressor to Inhibit Gastric Cancer by Targeting Fibroblast Growth Factor Receptor-2
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - January 13, 2022 Category: Cancer & Oncology Authors: Xiang Gao Huiqi Liu Qiong Wu Rong Wang Mingyu Huang Qiang Ma Yongnian Liu Source Type: research

Acknowledgment of Reviewers 2021
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - January 12, 2022 Category: Cancer & Oncology Source Type: research

A Pilot Study of Hepatic Irradiation with Yttrium90 Microspheres Followed by Immunotherapy with Ipilimumab and Nivolumab for Metastatic Uveal Melanoma
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - January 12, 2022 Category: Cancer & Oncology Authors: David R. Minor Kevin B. Kim Ricky T. Tong Max C. Wu Mohammed Kashani-Sabet Marlana Orloff David J. Eschelman Carlin F. Gonsalves Robert D. Adamo Pramila R. Anne Jason J. Luke Devron Char Takami Sato Source Type: research